Abstract. We determined HLA types in 110 Japanese patients with non-insulin-dependent diabetes mellitus (NIDDM) and studied the relationship between the HLA phenotypes and clinical features. Sixty-nine patients with insulin-dependent diabetes mellitus (IDDM) and 100 healthy blood donors served as controls. Concerning HLA DR and DQ loci, frequencies of DR4, DRw9 and DQw3.2 were higher, and those of DR2, DRw8, DRw 11, DRw12 and DQw1 were lower in patients with IDDM compared than in healthy controls. There were no differences between NIDDM and normal controls in the frequency of a particular HLA DR antigen except for a decreased frequency in DRw 11 in the former. The frequency of DQw3.2 antigen in NIDDM was intermediate between IDDM and normal controls. There were some differences between DQw3.2-positive and -negative NIDDM patients in clinical features. Those who showed low C-peptide responses during oral glucose tolerance test were more frequently found among DQw3.2-positive NIDDM patients. These results suggest that Type 1 diabetes mellitus may have a mild clinical course and is found among the Japanese NIDDM population.
IT IS NOW well established that insulin dependent diabetes mellitus (IDDM) (Type 1 diabetes) is associated with particular HLA antigen types; it has positive associations with DR3 and DR4 in Caucasians [1] [2] [3] and with DR4 and DRw9 in Japanese [2, 4, 5] . On the other hand, noninsulin-dependent diabetes mellitus (NIDDM) has no association with HLA antigens. However, NIDDM, defined on the basis of clinical findings, is a heterogenous disorder, and the possibility that a certain subtype of NIDDM has a positive association with HLA types could not be ruled out. It has recently been recognized that Type 1 diabetes could develop as NIDDM at first and that, with a gradual decrease in the pancreatic 13 cells by an autoimmune process, the diabetes becomes insulin-dependent 2 to 3 yr after its onset [6, 7] . 
Materials and Methods

Subjects
Patients with NIDDM (62 females and 48 males) were randomly selected for the HLA study from those who visited the diabetes clinic of Kyoto University Hospital. Criteria of NIDDM we used for the study were 1) non-ketosis proness, 2) mild onset after the age of 30, and 3) no requirement of insulin therapy at least for 1 yr from the diagnosis. served as controls for the HLA study. Our IDDM criteria were 1) acute onset of severe diabetic symptoms, 2) a lack of endogenous insulin secretion, 3) ketosis proness, and 4) requirement of insulin therapy immediately or within 1 yr after the diagnosis. All subjects were Japanese.
HLA typing A, B, C, DR and DQ loci were determined by Terasaki's microcytotoxicity technique. HLA antigens examined were Al, 2, 3, 9, 10, 11, 24, 26, 31, 34; B5, 7, 8, 12, 13, 15, 17, w22, 27, 35, 37, 38, 39, w46, w48, 51, w52, w54, 55, w56, w59, w60, w61, 67, 70, w71; Cw1 , w3, w4, w7, x46; DR 1, 2, 3, 4, 7, w8, w9, wll , w12, w13, w14; DQw l , w2, w3.1 and w3.2. We used the standard sera from the 7th and 8th Japan Histocompatibility Workshops and Red Cross Histocompatibility Workshop. As for DQw3, we determined split antigens DQw3. 1 
Results
Phenotype frequencies of HLA-DR antigens in 100 healthy blood donors, 69 patients with IDDM, and 110 with NIDDM are shown in Table 1 . The frequencies of DR4 and DRw9 were higher and those of DR2, DRw8, DRw 11 and DRw12 were lower in IDDM than in healthy blood donors. There were no differences between frequencies of particular DR antigens in patients with NIDDM and healthy controls except for DRw 11 antigen which was decreased in the former. Concerning HLA A, B and C loci there were no differences between healthy controls and patients with NIDDM (data not shown). The frequency of Bw54 was higher in IDDM than in healthy controls (Bw54; 37 vs 13%, p<0.005). Thirty-eight subjects with IDDM and 103 subjects with NIDDM were subjected to HLA-DQ typing. The frequency of DQw 1 was lower in IDDM, whereas that of DQw3.2 was higher in both IDDM and NIDDM than in healthy controls ( Table 2 ). The frequency of DQw3.2 in NIDDM was intermediate between IDDM and normal controls. Next we studied the relationships between particular HLA types and clinical features in patients with NIDDM. As clinical parameters, we selected the age at onset, body mass index at the time of maximal body weight, duration from the onset to commencement of insulin therapy (in insulintreated patients) and serum C-peptide responses during 75 g OGTT. As shown in Table 3 , the body mass index and presence or absence of insulin therapy were not related to HLA antigens. Age at onset was slightly lower in DQw3.2-positive patients than in those without this antigen (p<0.05). The HLA antigen DQw3.2 was also associated with low C-peptide responses (RR=6.0,p<0.025). Among insulin-treated diabetics, those who started insulin therapy within 5 yr after the onset were more frequently found in patients with DR4 and with DQw3.2 than those negative for these antigens (DR4; 40% vs 18%, DQw3.2; 36% vs 14%). However the differences did not reach statistical significance.
Discussion
The present study demonstrated that Japanese patients with IDDM had higher frequency of HLA Bw54, DR4 and DRw9 and lower frequency of HLA DR2 than in control subjects. This observation confirmed previous reports in Japanese patients with IDDM [4, 5, 8] . In the present study we further found that the frequency of DQw3.2 was higher in IDDM than in control subjects. This al.
[ therefore, that the association between NIDDM and HLA types differs among races. The incidence of IDDM in the Japanese population who live in Japan has been reported to be one [16] .
Assuming 
